Sort   by:  
 Page size 
Alternative lengthening of telomeres (ALT) supports telomere maintenance and replicative immortality in around 10-15% of cancers, thus representing a compelling target for therapy.To identify anti-cancer drugs that can be repurposed as ALT-centered therapies, we performed for a compound library scre...
ORGANISM(S): Homo sapiens (Human) 
2023-02-20 | PXD037501 | Pride
Characterization of PAXIP1 in alternative lengthening of telomeres
An inability to replicate the genome can cause replication stress and genome instability. Here, we develop BLOCK-ID, a proteomic method to identify and visualize proteins at stressed replication forks. This approach successfully identified novel mediators of the replication stress response, includin...
ORGANISM(S): Homo sapiens (Human) 
2026-08-31 | PXD063658 | Pride
Functional loss of ATRX and telomerase activates Alternative Lengthening of Telomeres (ALT)
Signalling inhibition by ponatinib disrupts alternative lengthening of telomeres (ALT)
An inability to replicate the genome can cause replication stress and genome instability. Here, we develop BLOCK-ID, a proteomic method to identify and visualize proteins at stressed replication forks. This approach successfully identified novel mediators of the replication stress response, includin...
ORGANISM(S): Homo sapiens (Human) 
2026-08-31 | PXD057112 | Pride
Most sarcomas have complex karyotype and are characterized by multiple chromosomal rearrangements. Moreover, sarcomas very frequently maintain their telomeres by recombination in the process called Alternative Lengthening of Telomeres (ALT) which enables their continuous growth and immortalization. ...
ORGANISM(S): Homo sapiens 
Sort   by:  
 Page size